Congratulations to Spirit Scientific (7790.TWO) on winning two Bronze Medals at the Taiwan Innotech Expo 2025 (TIE 2025)! 

Both awarded patents showcase advancements built on their Biomaterial Lyophilization Technology (BMLT):

• Growth-factor-rich dry powder for inflammation & tissue repair
• Standardized platelet-based compositions for clinical use

These achievements highlight Spirit Scientific’s expanding capabilities in next-gen regenerative solutions.

At the 2025 Taiwan Orthopaedic Association (2025 TOA) Annual Meeting, their innovations also drew attention for addressing major PRP pain points — including inconsistent platelet concentration and lack of dose standardization, which limit treatment outcomes.

Their PLT lyophilized platelet platform and the new PLTgel™ sustained-release system offer:

•  Precise, fixed dosing
• Room-temperature stability
• Optimized growth-factor release for long-term tissue repair

A promising step forward for osteoarthritis, soft-tissue injuries, and sports medicine.

編輯推薦

• 思必瑞特上半年營收年增39%！獲利動能強勁  
• 【影音】將生物材料藥品化：思必瑞特創新再生醫學